Form D Explorer

Form C/A — Rejuvine Life Sciences, Inc.

0001520138-24-000480 · filed 2024-12-26 · via SILICON PRAIRIE CAPITAL PARTNERS, LLC

Offering

Target: $10,000
Maximum: $1,235,000
Security type: Other
Price per security: $1.0000
Deadline: —
Oversubscription: Accepted

Issuer

Name: Rejuvine Life Sciences, Inc.
CIK: 2008980
Entity: Corporation
Jurisdiction: DE
Address: 651 North Broad Street
Middletown, DE 19709
Phone: —

Most recent fiscal year financials

Total assets

$205,052

Cash

—

Short-term debt

—

Long-term debt

$3,910,000

Revenues

$4,230

COGS

$-5,076

Taxes paid

—

Net income

$-205,500

View original on SEC EDGAR.